Subcutaneous Drug Injection Review (PMC) Pharmacologic considerations of the subcutaneous route Related research, protocols, and guides Explore the available research context, protocol variants or comparisons, and practical guides
BPC-157 is on the World Anti-Doping Agency (WADA) Prohibited List under category S0 (non-approved substances)
Injections : 1,000 mcg IM weekly or monthly depending on need [*]
Relying on unproven substances diverts individuals from evidence-based treatments that are safer and more effective
Weight and body composition management Again, 0.2 to 0.3 mg per night is the standard range
Most oral supplements of BPC-157 range from 200 mcg to 500 mcg daily, while injectable BPC-157 is typically used in 250500 mcg doses once or twice a day, often injected near the injury site for localized healing